Non-Opioid Pain Treatment Global Market Report 2025

Description

A non-opioid pain treatment refers to therapy or medication designed to manage pain without the use of opioid drugs. These treatments alleviate pain through mechanisms other than opioid receptor activation and include options such as acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), certain antidepressants, anticonvulsants for nerve-related pain, as well as physical therapies such as physiotherapy, exercise, heat or cold therapy, and massage.

The primary product types of non-opioid pain treatments include medical cannabis, menthol-based products, omega-3 fatty acid formulations, botulinum toxins, and capsaicin-derived products. Medical cannabis refers to the therapeutic use of cannabis or its extracts to manage symptoms or various health conditions. The drug classes involved in these treatments comprise NSAIDs, acetaminophen, local anesthetics, antidepressants, anticonvulsants, corticosteroids, and others, delivered via oral, topical, injectable, and other routes. These treatments are distributed through hospital pharmacies, retail pharmacies, drugstores, and mail-order pharmacies. Common applications include orthopedic and musculoskeletal pain, postoperative pain, cancer-related pain, neuropathic pain, and other conditions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The non-opioid pain treatment market research report is one of a series of new reports from The Business Research Company that provides non-opioid pain treatment market statistics, including non-opioid pain treatment industry global market size, regional shares, competitors with a non-opioid pain treatment market share, detailed non-opioid pain treatment market segments, market trends and opportunities, and any further data you may need to thrive in the non-opioid pain treatment industry. This non-opioid pain treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The non-opioid pain treatment market size has grown strongly in recent years. It will grow from $50.63 billion in 2024 to $55.31 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth during the historic period can be attributed to the increasing prevalence of chronic pain, greater patient preference for safer alternatives, rising public awareness of opioid-related risks, higher demand for non-addictive treatment options, and expanded healthcare provider initiatives.

The non-opioid pain treatment market size is expected to see strong growth in the next few years. It will grow to $77.67 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The expected growth in the forecast period can be linked to increasing demand for personalized pain management, greater adoption of non-opioid therapies, a growing geriatric population, rising investment in the development of non-opioid drugs, and enhanced government support and reimbursement policies. Key trends anticipated in the forecast period include advancements in drug delivery systems, the integration of multidisciplinary care models, technology-enabled personalized medicine, progress in non-opioid pharmacological options, and innovations in patient monitoring tools.

The increasing incidence of sports-related injuries is expected to drive the growth of the non-opioid pain treatment market in the coming years. Sports-related injuries are physical injuries that occur during or as a result of sports or exercise activities. The rise in these injuries is linked to growing participation in high-intensity sports and recreational activities, which heightens the risk of physical trauma for athletes. Non-opioid pain treatment plays a crucial role in managing such injuries by providing effective pain relief and reducing inflammation without the risks associated with opioid use, enabling faster recovery, improved function, and safer long-term care. For example, in October 2024, according to Howden Group Holdings Ltd, a UK-based insurance intermediary, Europe's top five football leagues reported 4,123 injuries during the 2023/24 season, representing a 4% increase from the previous season. As a result, the rising incidence of sports-related injuries is fueling the growth of the non-opioid pain treatment market.

Companies in the non-opioid pain treatment market are focusing on developing innovative drug formulations, such as non-opioid oral treatments, to provide effective pain relief while minimizing risks related to opioid use and addiction. Non-opioid oral treatments refer to pain-relieving drugs taken orally that do not contain opioids and work through alternative mechanisms, such as reducing inflammation, modulating nerve activity, or acting on specific receptors, to manage pain without the addiction potential or respiratory depression linked to opioids. For instance, in July 2025, Vertex Pharmaceuticals Incorporated, a US-based biotechnology firm, launched JOURNAVX, a first-in-class non-opioid therapy designed to provide effective relief for moderate-to-severe acute pain. This advanced treatment uses targeted modulation of pain pathways, features a favorable safety profile, and delivers rapid pain control, reducing dependency risks and enhancing patient outcomes. It ensures effective pain management, supports faster recovery, and improves quality of life for patients experiencing acute pain.

In May 2025, Eli Lilly and Company, a US-based pharmaceutical firm, acquired SiteOne Therapeutics Inc. for an undisclosed sum. Through this acquisition, Eli Lilly aims to strengthen its neuroscience pipeline by developing and commercializing STC-004, a non-opioid Nav1.8 inhibitor that offers a safer and effective option for chronic pain treatment without the risk of addiction. SiteOne Therapeutics Inc. is a US-based pharmaceutical company that specializes in non-opioid pain treatments.

Major players in the non-opioid pain treatment market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc, Novartis AG, GSK plc, Amgen Inc., Teva Pharmaceutical Industries Limited, Vertex Pharmaceuticals Incorporated, SUN PHARMACEUTICAL INDUSTRIES LIMITED, Perrigo Company Public Limited Company, Dr. Reddy's Laboratories, HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY, Pacira BioSciences Inc, Heron Therapeutics Inc, AFT Pharmaceuticals Limited, Vivozon Pharmaceutical Co. Ltd, Levicept Ltd, Algiax Pharmaceuticals GmbH, Latigo Biotherapeutics Inc, Hyloris Pharmaceuticals SA.

North America was the largest region in the non-opioid pain treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in non-opioid pain treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the non-opioid pain treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The non-opioid pain treatment market consists of revenues earned by entities by providing services such as physical therapy services, cognitive and behavioral therapies, and interventional pain management. The market value includes the value of related goods sold by the service provider or included within the service offering. The non-opioid pain treatment market also includes sales of antidepressants, anticonvulsants, and acupuncture kits. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Non-Opioid Pain Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on non-opioid pain treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for non-opioid pain treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The non-opioid pain treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Medical Cannabis; Menthol-Containing; Omega 3 Fatty Acid-Containing; Botulinum Toxins; Capsaicin-Derived; Other Products
2) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (Nsaids); Acetaminophen; Local Anesthetics; Antidepressants; Anticonvulsants; Corticosteroids; Other Drug Classes
3) By Route Of Administration: Oral; Topical; Injectable; Other Route Of Administrations
4) By Distribution Channel: Hospitals Pharmacies; Retail Pharmacies; Drug Stores; Mail Order Pharmacies
5) By Application: Orthopedic And Musculoskeletal Pain; Postoperative Pain; Cancer Pain; Neuropathic Pain; Other Applications
Subsegments:
1) By Medical Cannabis: Cannabidiol Based Products; Tetrahydrocannabinol Based Products; Combined Cannabinoid Products
2) By Menthol Containing: Topical Creams; Gels; Sprays
3) By Omega 3 Fatty Acid Containing: Fish Oil Derived Supplements; Algae Derived Supplements; Krill Oil Derived Supplements
4) By Botulinum Toxins: Onabotulinumtoxin A; Abobotulinumtoxin A; Incobotulinumtoxin A
5) By Capsaicin Derived: Low Concentration Creams; High Concentration Patches; Nasal Sprays
6) By Other Products: Magnesium Based Products; Acupuncture Devices; Transcutaneous Electrical Nerve Stimulation Devices
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; AbbVie Inc; Novartis AG; GSK plc; Amgen Inc.; Teva Pharmaceutical Industries Limited; Vertex Pharmaceuticals Incorporated; SUN PHARMACEUTICAL INDUSTRIES LIMITED; Perrigo Company Public Limited Company; Dr. Reddy's Laboratories; HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY; Pacira BioSciences Inc; Heron Therapeutics Inc; AFT Pharmaceuticals Limited; Vivozon Pharmaceutical Co. Ltd; Levicept Ltd; Algiax Pharmaceuticals GmbH; Latigo Biotherapeutics Inc; Hyloris Pharmaceuticals SA
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r37837

1. Executive Summary

2. Non-Opioid Pain Treatment Market Characteristics

3. Non-Opioid Pain Treatment Market Trends And Strategies

4. Non-Opioid Pain Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Non-Opioid Pain Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Non-Opioid Pain Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Non-Opioid Pain Treatment Market Growth Rate Analysis
5.4. Global Non-Opioid Pain Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Non-Opioid Pain Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Non-Opioid Pain Treatment Total Addressable Market (TAM)

6. Non-Opioid Pain Treatment Market Segmentation

6.1. Global Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medical Cannabis
Menthol-Containing
Omega 3 Fatty Acid-Containing
Botulinum Toxins
Capsaicin-Derived
Other Products
6.2. Global Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nonsteroidal Anti-Inflammatory Drugs (Nsaids)
Acetaminophen
Local Anesthetics
Antidepressants
Anticonvulsants
Corticosteroids
Other Drug Classes
6.3. Global Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Topical
Injectable
Other Route Of Administrations
6.4. Global Non-Opioid Pain Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals Pharmacies
Retail Pharmacies
Drug Stores
Mail Order Pharmacies
6.5. Global Non-Opioid Pain Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Orthopaedic And Musculoskeletal Pain
Postoperative Pain
Cancer Pain
Neuropathic Pain
Other Applications
6.6. Global Non-Opioid Pain Treatment Market, Sub-Segmentation Of Medical Cannabis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cannabidiol Based Products
Tetrahydrocannabinol Based Products
Combined Cannabinoid Products
6.7. Global Non-Opioid Pain Treatment Market, Sub-Segmentation Of Menthol Containing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Creams
Gels
Sprays
6.8. Global Non-Opioid Pain Treatment Market, Sub-Segmentation Of Omega 3 Fatty Acid Containing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fish Oil Derived Supplements
Algae Derived Supplements
Krill Oil Derived Supplements
6.9. Global Non-Opioid Pain Treatment Market, Sub-Segmentation Of Botulinum Toxins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
OnabotulinumtoxinA
AbobotulinumtoxinA
IncobotulinumtoxinA
6.10. Global Non-Opioid Pain Treatment Market, Sub-Segmentation Of Capsaicin Derived, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Low Concentration Creams
High Concentration Patches
Nasal Sprays
6.11. Global Non-Opioid Pain Treatment Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Magnesium Based Products
Acupuncture Devices
Transcutaneous Electrical Nerve Stimulation Devices

7. Non-Opioid Pain Treatment Market Regional And Country Analysis

7.1. Global Non-Opioid Pain Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Non-Opioid Pain Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Non-Opioid Pain Treatment Market

8.1. Asia-Pacific Non-Opioid Pain Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Non-Opioid Pain Treatment Market

9.1. China Non-Opioid Pain Treatment Market Overview
9.2. China Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Non-Opioid Pain Treatment Market

10.1. India Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Non-Opioid Pain Treatment Market

11.1. Japan Non-Opioid Pain Treatment Market Overview
11.2. Japan Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Non-Opioid Pain Treatment Market

12.1. Australia Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Non-Opioid Pain Treatment Market

13.1. Indonesia Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Non-Opioid Pain Treatment Market

14.1. South Korea Non-Opioid Pain Treatment Market Overview
14.2. South Korea Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Non-Opioid Pain Treatment Market

15.1. Western Europe Non-Opioid Pain Treatment Market Overview
15.2. Western Europe Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Non-Opioid Pain Treatment Market

16.1. UK Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Non-Opioid Pain Treatment Market

17.1. Germany Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Non-Opioid Pain Treatment Market

18.1. France Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Non-Opioid Pain Treatment Market

19.1. Italy Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Non-Opioid Pain Treatment Market

20.1. Spain Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Non-Opioid Pain Treatment Market

21.1. Eastern Europe Non-Opioid Pain Treatment Market Overview
21.2. Eastern Europe Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Non-Opioid Pain Treatment Market

22.1. Russia Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Non-Opioid Pain Treatment Market

23.1. North America Non-Opioid Pain Treatment Market Overview
23.2. North America Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Non-Opioid Pain Treatment Market

24.1. USA Non-Opioid Pain Treatment Market Overview
24.2. USA Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Non-Opioid Pain Treatment Market

25.1. Canada Non-Opioid Pain Treatment Market Overview
25.2. Canada Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Non-Opioid Pain Treatment Market

26.1. South America Non-Opioid Pain Treatment Market Overview
26.2. South America Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Non-Opioid Pain Treatment Market

27.1. Brazil Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Non-Opioid Pain Treatment Market

28.1. Middle East Non-Opioid Pain Treatment Market Overview
28.2. Middle East Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Non-Opioid Pain Treatment Market

29.1. Africa Non-Opioid Pain Treatment Market Overview
29.2. Africa Non-Opioid Pain Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Non-Opioid Pain Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Non-Opioid Pain Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Non-Opioid Pain Treatment Market Competitive Landscape And Company Profiles

30.1. Non-Opioid Pain Treatment Market Competitive Landscape
30.2. Non-Opioid Pain Treatment Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. GSK plc Overview, Products and Services, Strategy and Financial Analysis

31. Non-Opioid Pain Treatment Market Other Major And Innovative Companies

31.1. Amgen Inc.
31.2. Teva Pharmaceutical Industries Limited
31.3. Vertex Pharmaceuticals Incorporated
31.4. SUN PHARMACEUTICAL INDUSTRIES LIMITED
31.5. Perrigo Company Public Limited Company
31.6. Dr. Reddy's Laboratories
31.7. HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY
31.8. Pacira BioSciences Inc
31.9. Heron Therapeutics Inc
31.10. AFT Pharmaceuticals Limited
31.11. Vivozon Pharmaceutical Co. Ltd
31.12. Levicept Ltd
31.13. Algiax Pharmaceuticals GmbH
31.14. Latigo Biotherapeutics Inc
31.15. Hyloris Pharmaceuticals SA

32. Global Non-Opioid Pain Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Non-Opioid Pain Treatment Market

34. Recent Developments In The Non-Opioid Pain Treatment Market

35. Non-Opioid Pain Treatment Market High Potential Countries, Segments and Strategies

35.1 Non-Opioid Pain Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Non-Opioid Pain Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Non-Opioid Pain Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer